Marty joined Bessor following a more than 35-year career at Eli Lilly and Company, where he was most recently Director of Product Research and Development and Six Sigma Champion at Lilly Research Laboratories. He led multiple development teams for drugs including human growth hormone (Humatrope®), atomoxetine (Strattera®) and pergolide (Permax®). He joined Lilly Research Labs after completing a post-doctoral fellowship at the Roche Institute of Molecular Biology. He holds a BA degree in Psychology from Providence College, and MS and PhD degrees in Pharmacology and Toxicology from the University of Rhode Island. Marty also served as a Vice President of Quality Assurance and Regulatory Affairs at Mapp Biopharmaceutical, a biotech developing novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense for more than 6 years. Dr. Hynes teaches as an adjunct professor of Biotechnology Innovation and Regulatory Science at Purdue University.